ReviewCancers2026

Comprehensive Safety and Efficacy Evaluation of Immunotherapy Combination Approaches Versus Tyrosine Kinase Inhibitor Monotherapy as First-Line Treatment of Hepatocellular Carcinoma: A Network and Individual Patient Data (IPD) Meta-Analysis.

Abdullah Esmail et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.